Cyclic voltammetry as a measuring tool in Parkinson’s disease and associated psychiatric commorbidities

Introduction Despite the rapid increase in disability and death due to Parkinson’s disease and associated psychiatric comorbidities (psychosis, depression, cognitive impairment, anxiety), the quest for a clear pathophysiological mechanism and treatment remains elusive. Numerous studies aim to ident...

Full description

Bibliographic Details
Main Authors: C. A. Ciobanu, I. Ionita, A.-I. Mihailescu, A.-M. Ciobanu
Format: Article
Language:English
Published: Cambridge University Press 2023-03-01
Series:European Psychiatry
Online Access:https://www.cambridge.org/core/product/identifier/S0924933823015973/type/journal_article
_version_ 1797616086801186816
author C. A. Ciobanu
I. Ionita
A.-I. Mihailescu
A.-M. Ciobanu
author_facet C. A. Ciobanu
I. Ionita
A.-I. Mihailescu
A.-M. Ciobanu
author_sort C. A. Ciobanu
collection DOAJ
description Introduction Despite the rapid increase in disability and death due to Parkinson’s disease and associated psychiatric comorbidities (psychosis, depression, cognitive impairment, anxiety), the quest for a clear pathophysiological mechanism and treatment remains elusive. Numerous studies aim to identify a metabolomic fingerprint for PD and new, promising biomarkers are discovered with implications beyond neurodegenerative diseases, such as novel markers as predictors of bipolar type in depressed patients.Changes in neuronal microenvironment employ electrochemical techniques, such as cyclic voltammetry, used in both animal and human models of PD to monitor dopamine (DA) alterations in vivo, with high spatial and temporal resolution. Objectives Our aim is to investigate the latest scientific literature on PD and associated neuropsychiatric disorders and review the applications cyclic voltammetry has in recent technological advances in the field. Methods To gain a broad understanding of the subject, we have consulted multiple scientific literature databases (PubMed, Google Academic, Science Direct) using the keywords “cyclic voltammetry, Parkinson’s disease, psychiatric disorders, dopamine” and included original research articles published in the last 10 years Results The first in situ measurement of DA release in the human brain has been demonstrated in a sequential investment task, with implications for future research in decision-making behavior. One study combines cyclic voltammetry and wireless telemetry for in vivo recording of changes in extracellular levels of DA, with high temporal and spatial resolution. Disulfide nanorod-graphene-β-cyclodextrin nanocomposites biosensors have been succesfully used in detecting DA in rodent brain and human blood serum samples, with implications for minimally invasive measuring techniques. Animal studies use cyclic voltammetry to monitor changes in DA levels in cerebrospinal fluid and plasma of mouse models of PD and investigate DA metabolism, release, uptake and receptor sensitivity in Knock-out mice, with implications for the diurnal variation of extracellular DA tone and release.Furthermore, a human alpha-synuclein-expressing mouse model of PD exhibited increased extracellular DA concentrations, decreased DA uptake and relieved paired-stimulus depression. Conclusions Cyclic voltammetry is a powerful tool in the expansion to humans of electrochemical recording techniques in PD. The final aim is to investigate DA neuron physiology before neurodegeneration onset and to measure neurotransmitter release in real time. Disclosure of Interest None Declared
first_indexed 2024-03-11T07:36:12Z
format Article
id doaj.art-b09094f8439d4579945fbd71d4bd7b9e
institution Directory Open Access Journal
issn 0924-9338
1778-3585
language English
last_indexed 2024-03-11T07:36:12Z
publishDate 2023-03-01
publisher Cambridge University Press
record_format Article
series European Psychiatry
spelling doaj.art-b09094f8439d4579945fbd71d4bd7b9e2023-11-17T05:09:49ZengCambridge University PressEuropean Psychiatry0924-93381778-35852023-03-0166S757S75810.1192/j.eurpsy.2023.1597Cyclic voltammetry as a measuring tool in Parkinson’s disease and associated psychiatric commorbiditiesC. A. Ciobanu0I. Ionita1A.-I. Mihailescu2A.-M. Ciobanu3Faculty of Medicine, “Titu Maiorescu” University, BucharestFaculty of Medicine, “Carol Davila” University of Medicine and PharmacyFaculty of Medicine, “Carol Davila” University of Medicine and Pharmacy Ist Department, “Prof. Dr. Alex Obregia” Hospital, Bucharest, RomaniaFaculty of Medicine, “Carol Davila” University of Medicine and Pharmacy Ist Department, “Prof. Dr. Alex Obregia” Hospital, Bucharest, Romania Introduction Despite the rapid increase in disability and death due to Parkinson’s disease and associated psychiatric comorbidities (psychosis, depression, cognitive impairment, anxiety), the quest for a clear pathophysiological mechanism and treatment remains elusive. Numerous studies aim to identify a metabolomic fingerprint for PD and new, promising biomarkers are discovered with implications beyond neurodegenerative diseases, such as novel markers as predictors of bipolar type in depressed patients.Changes in neuronal microenvironment employ electrochemical techniques, such as cyclic voltammetry, used in both animal and human models of PD to monitor dopamine (DA) alterations in vivo, with high spatial and temporal resolution. Objectives Our aim is to investigate the latest scientific literature on PD and associated neuropsychiatric disorders and review the applications cyclic voltammetry has in recent technological advances in the field. Methods To gain a broad understanding of the subject, we have consulted multiple scientific literature databases (PubMed, Google Academic, Science Direct) using the keywords “cyclic voltammetry, Parkinson’s disease, psychiatric disorders, dopamine” and included original research articles published in the last 10 years Results The first in situ measurement of DA release in the human brain has been demonstrated in a sequential investment task, with implications for future research in decision-making behavior. One study combines cyclic voltammetry and wireless telemetry for in vivo recording of changes in extracellular levels of DA, with high temporal and spatial resolution. Disulfide nanorod-graphene-β-cyclodextrin nanocomposites biosensors have been succesfully used in detecting DA in rodent brain and human blood serum samples, with implications for minimally invasive measuring techniques. Animal studies use cyclic voltammetry to monitor changes in DA levels in cerebrospinal fluid and plasma of mouse models of PD and investigate DA metabolism, release, uptake and receptor sensitivity in Knock-out mice, with implications for the diurnal variation of extracellular DA tone and release.Furthermore, a human alpha-synuclein-expressing mouse model of PD exhibited increased extracellular DA concentrations, decreased DA uptake and relieved paired-stimulus depression. Conclusions Cyclic voltammetry is a powerful tool in the expansion to humans of electrochemical recording techniques in PD. The final aim is to investigate DA neuron physiology before neurodegeneration onset and to measure neurotransmitter release in real time. Disclosure of Interest None Declaredhttps://www.cambridge.org/core/product/identifier/S0924933823015973/type/journal_article
spellingShingle C. A. Ciobanu
I. Ionita
A.-I. Mihailescu
A.-M. Ciobanu
Cyclic voltammetry as a measuring tool in Parkinson’s disease and associated psychiatric commorbidities
European Psychiatry
title Cyclic voltammetry as a measuring tool in Parkinson’s disease and associated psychiatric commorbidities
title_full Cyclic voltammetry as a measuring tool in Parkinson’s disease and associated psychiatric commorbidities
title_fullStr Cyclic voltammetry as a measuring tool in Parkinson’s disease and associated psychiatric commorbidities
title_full_unstemmed Cyclic voltammetry as a measuring tool in Parkinson’s disease and associated psychiatric commorbidities
title_short Cyclic voltammetry as a measuring tool in Parkinson’s disease and associated psychiatric commorbidities
title_sort cyclic voltammetry as a measuring tool in parkinson s disease and associated psychiatric commorbidities
url https://www.cambridge.org/core/product/identifier/S0924933823015973/type/journal_article
work_keys_str_mv AT caciobanu cyclicvoltammetryasameasuringtoolinparkinsonsdiseaseandassociatedpsychiatriccommorbidities
AT iionita cyclicvoltammetryasameasuringtoolinparkinsonsdiseaseandassociatedpsychiatriccommorbidities
AT aimihailescu cyclicvoltammetryasameasuringtoolinparkinsonsdiseaseandassociatedpsychiatriccommorbidities
AT amciobanu cyclicvoltammetryasameasuringtoolinparkinsonsdiseaseandassociatedpsychiatriccommorbidities